Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00166361Not ApplicableCompleted

Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent

Role: collaborator

NCT00662350Completed

Temperature Mapping of the Prostate With the Wallterm™ System

Role: lead

NCT00549159Phase 4Unknown

CavatermTM vs TCRE in Women With DUB

Role: lead

All 3 trials loaded